Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
S&P 500 Is Near a Correction, but That May Bode Well for 2025's Performance
Florida Rep. Jared Moskowitz Sold Up to $15K Worth of West Pharmaceutical Servs Stock
West to Participate in Upcoming Investor Conferences
Estimating The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)
DBS Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $370
Strong Market Position and Growth Potential Drive Buy Rating for West Pharmaceutical Services
Play Defense With Goldman's Cheap Healthcare Picks
S&P 500 February Winners, Losers as Stock Benchmark Ends Monthly Journey in the Red
U.S. Stock Market Gold Digging | The elephant dances! Berkshire's stock price hits a historic high, with 'a share at $0.75 million' leading globally; can it rise another 43%? Nike surged nearly 5% overnight against the market, with Jefferies Financial rai
Editor's note: "Gold Mining in US Stocks" closely follows market dynamics daily, insightfully analyzing and summarizing popular fluctuations and significantly rising stocks, providing mooers with a multi-dimensional reference for investment opportunities, helping mooers grasp investment opportunities at a glance!
West Pharmaceutical Services Inc. Stock Rises 4.8%, Outperforms Competitors
Still in the Bull Camp? These Are the Most Oversold S&P 500 Stocks
Rumors Swirl About Kanye West and Bianca Censori Splitting Up: So What About His $50 Million Property Portfolio?
Notable Healthcare Headlines for the Week: UnitedHealth, Moderna, Sanofi in Focus
West Pharmaceutical Services To Go Ex-Dividend On April 30th, 2025 With 0.21 USD Dividend Per Share
February 21st (Eastern Time) - $West Pharmaceutical Services(WST.US)$ is trading ex-dividend on April 30th, 2025.Shareholders of record on April 30th, 2025 will receive 0.21 USD dividend per share
Top 2 Health Care Stocks That May Rocket Higher This Month
West Pharmaceutical Services Maintains Quarterly Dividend at $0.21 Per Share; Payable May 7 to Shareholders of Record on April 30
Press Release: West Announces Second-Quarter Dividend
Express News | West Pharmaceutical Services Inc : Jefferies Cuts Target Price to $240 From $393
West Pharmaceutical Services | 10-K: FY2024 Annual Report